Literature DB >> 15763625

Towards a better understanding of the dissociation behavior of liposome-oligonucleotide complexes in the cytosol of cells.

B Lucas1, K Remaut, N N Sanders, K Braeckmans, S C De Smedt, J Demeester.   

Abstract

To obtain real breakthroughs in antisense therapy, it is necessary to understand the cellular behavior of antisense delivery systems. Fluorescence fluctuation spectroscopy (FFS), which measures in time fluorescence fluctuations in the excitation volume of a microscope and which can thus be applied on a cellular scale, shows potential for this purpose. In this study dual color FFS was explored to characterize the complexation (association and dissociation) between Cy5-labeled oligonucleotides (Cy5-ONs) and FITC-labeled cationic liposomes (FITC-liposomes) in respectively buffer, cell lysate and the cytosol of Vero cells. In Hepes buffer the association of the Cy5-ONs to the FITC-liposomes could be clearly observed from the high peaks of Cy5- and FITC-fluorescence, which appeared simultaneously in the excitation volume. This was explained by the fact that in the complexed state many Cy5-ONs and FITC-liposomes are bound to each other and thus move together through the excitation volume thereby resulting in high fluorescence 'FITC/Cy5-peaks'. FFS measurements on FITC-liposome/Cy5-ONs complexes in cell lysate revealed that a minor part of the Cy5-ONs was released from the complexes. The major part of the Cy5-ONs remained in the complexes, which also seemed to aggregate in cell lysate. In agreement with the measurements in cell lysate, after microinjection of FITC-liposome/Cy5-ONs complexes in the cytosol of Vero cells a part of the Cy5-ONs was released (as Cy-ONs were detected by FFS in the nuclei) while the other part remained bound (as Cy5-peaks were frequently observed in the cytosol). As will be explained, the Cy5-peaks could be due both to Cy5-ONs clustered with cytosol components and Cy5-ONs still complexed to FITC-liposomes with quenched FITC-fluorescence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763625     DOI: 10.1016/j.jconrel.2004.12.017

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  7 in total

1.  Transfection of living HeLa cells with fluorescent poly-cytosine encapsulated Ag nanoclusters.

Authors:  Yasuko Antoku; Jun-ichi Hotta; Hideaki Mizuno; Robert M Dickson; Johan Hofkens; Tom Vosch
Journal:  Photochem Photobiol Sci       Date:  2010-03-22       Impact factor: 3.982

2.  Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET.

Authors:  Yi-Ping Ho; Hunter H Chen; Kam W Leong; Tza-Huei Wang
Journal:  J Control Release       Date:  2006-09-22       Impact factor: 9.776

Review 3.  Understanding nonviral nucleic acid delivery with quantum dot-FRET nanosensors.

Authors:  Christopher L Grigsby; Yi-Ping Ho; Kam W Leong
Journal:  Nanomedicine (Lond)       Date:  2012-04       Impact factor: 5.307

4.  Lipopolyamine-mediated single nanoparticle formation of calf thymus DNA analyzed by fluorescence correlation spectroscopy.

Authors:  Noppadon Adjimatera; Teresa Kral; Martin Hof; Ian S Blagbrough
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

5.  Impact of phospholipids on plasmid packaging and toxicity of gemini nanoparticles.

Authors:  Chilbert Dong; Ildiko Badea; Masoomeh Poorghorban; Ronald Verrall; Marianna Foldvari
Journal:  J Mater Chem B       Date:  2015-09-29       Impact factor: 6.331

6.  The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery.

Authors:  Francesco Cardarelli; Luca Digiacomo; Cristina Marchini; Augusto Amici; Fabrizio Salomone; Giuseppe Fiume; Alessandro Rossetta; Enrico Gratton; Daniela Pozzi; Giulio Caracciolo
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

Review 7.  Solid-phase supported design of carriers for therapeutic nucleic acid delivery.

Authors:  Ana Krhac Levacic; Stephan Morys; Ernst Wagner
Journal:  Biosci Rep       Date:  2017-10-31       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.